Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Oaktree Acquisition (OAC) Competitors

OAC vs. TDOC, AUNA, SBC, LFMD, TOI, AIRS, SHLT, CCM, HIMS, and NVST

Should you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Oncology Institute (TOI), AirSculpt Technologies (AIRS), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), and Envista (NVST).

Oaktree Acquisition vs.

Oaktree Acquisition (NYSE:OAC) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

47.6% of Oaktree Acquisition shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Oaktree Acquisition has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.73, meaning that its stock price is 73% more volatile than the S&P 500.

Oaktree Acquisition has higher earnings, but lower revenue than Teladoc Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree AcquisitionN/AN/A$1.15MN/AN/A
Teladoc Health$2.57B0.49-$220.37M-$5.88-1.22

Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree AcquisitionN/A N/A N/A
Teladoc Health -37.91%-10.06%-4.86%

Teladoc Health received 680 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 62.78% of users gave Teladoc Health an outperform vote.

CompanyUnderperformOutperform
Oaktree AcquisitionOutperform Votes
3
100.00%
Underperform Votes
No Votes
Teladoc HealthOutperform Votes
683
62.78%
Underperform Votes
405
37.22%

In the previous week, Teladoc Health had 10 more articles in the media than Oaktree Acquisition. MarketBeat recorded 10 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Oaktree Acquisition's average media sentiment score of 0.00 beat Teladoc Health's score of -0.08 indicating that Oaktree Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Neutral
Teladoc Health Neutral

Teladoc Health has a consensus price target of $10.71, suggesting a potential upside of 48.93%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts clearly believe Teladoc Health is more favorable than Oaktree Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Teladoc Health
0 Sell rating(s)
12 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.37

Summary

Teladoc Health beats Oaktree Acquisition on 9 of the 15 factors compared between the two stocks.

Get Oaktree Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OAC vs. The Competition

MetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE Exchange
Market Cap$706.63M$1.01B$5.46B$18.79B
Dividend YieldN/AN/A5.43%4.09%
P/E RatioN/A16.4522.4332.61
Price / SalesN/A1.10391.4228.44
Price / Cash377.4536.0138.1817.53
Price / Book140.459.246.684.45
Net Income$1.15M-$52.07M$3.22B$1.02B

Oaktree Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OAC
Oaktree Acquisition
N/A$28.09
-0.2%
N/A+128.9%$706.63MN/A0.00N/AHigh Trading Volume
TDOC
Teladoc Health
3.4788 of 5 stars
$6.78
+4.1%
$10.82
+59.8%
-44.7%$1.18B$2.57B-1.175,100Upcoming Earnings
Analyst Forecast
AUNA
Auna
3.8976 of 5 stars
$6.71
+0.3%
$13.05
+94.5%
-1.0%$496.34M$4.39B17.6614,958
SBC
SBC Medical Group
N/A$4.01
-2.4%
N/AN/A$415.48M$205.42M0.00N/A
LFMD
LifeMD
2.6803 of 5 stars
$5.51
+2.1%
$11.43
+107.3%
-49.0%$245.88M$212.45M-8.62230Short Interest ↓
News Coverage
Positive News
TOI
Oncology Institute
0.7309 of 5 stars
$2.72
+13.8%
N/A+187.8%$207.64M$393.41M-3.52660Gap Down
AIRS
AirSculpt Technologies
1.6068 of 5 stars
$1.69
-0.4%
$3.75
+121.4%
-65.1%$98.41M$180.35M-12.00240Upcoming Earnings
News Coverage
SHLT
SHL Telemedicine
N/A$2.05
flat
N/AN/A$33.61M$55.94M0.00583
CCM
Concord Medical Services
0.6209 of 5 stars
$4.36
+2.2%
N/A-10.9%$18.91M$471.70M0.00970Analyst Forecast
Short Interest ↑
News Coverage
HIMS
Hims & Hers Health
3.7802 of 5 stars
$25.94
+0.4%
$38.25
+47.5%
+124.8%$5.75B$1.48B58.81650Analyst Forecast
Insider Trade
Gap Down
NVST
Envista
4.5223 of 5 stars
$14.91
+0.3%
$19.96
+33.9%
-21.7%$2.57B$2.51B-2.3012,700Upcoming Earnings
News Coverage

Related Companies and Tools


This page (NYSE:OAC) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners